Immunological and inflammatory functions of the interleukin-1 family.

More than any other cytokine family, the interleukin (IL)-1 family is closely linked to the innate immune response. This linkage became evident upon the discovery that the cytoplasmic domain of the IL-1 receptor type I is highly homologous to the cytoplasmic domains of all Toll-like receptors (TLRs). Thus, fundamental inflammatory responses such as the induction of cyclooxygenase type 2, increased expression of adhesion molecules, or synthesis of nitric oxide are indistinguishable responses of both IL-1 and TLR ligands. Both families nonspecifically affect antigen recognition and lymphocyte function. IL-1beta is the most studied member of the IL-1 family because of its role in mediating autoinflammatory diseases. Although the TLR and IL-1 families evolved to assist in host defense against infection, unlike the TLR family, the IL-1 family also includes members that suppress inflammation, both specifically within the IL-1 family but also nonspecifically for TLR ligands and the innate immune response.

[1]  P. Tak,et al.  Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis , 2006, European Journal of Drug Metabolism and Pharmacokinetics.

[2]  P. Halban,et al.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. , 2008, The Journal of clinical endocrinology and metabolism.

[3]  D. Mann,et al.  Cutting Edge: IL-1 Controls the IL-23 Response Induced by Gliadin, the Etiologic Agent in Celiac Disease1 , 2008, The Journal of Immunology.

[4]  C. Dinarello,et al.  120 The IL-1 family member IL-1F7 reduces innate immunity by inhibiting Toll-like receptor and IL-1 signaling pathways , 2008 .

[5]  L. Punzi,et al.  Resistant Behçet disease responsive to anakinra. , 2008, Annals of internal medicine.

[6]  G. Yancopoulos,et al.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. , 2008, Arthritis and rheumatism.

[7]  Andrew G. Watts,et al.  A Key Role for Redox Signaling in Rapid P2X7 Receptor-Induced IL-1β Processing in Human Monocytes1 , 2008, The Journal of Immunology.

[8]  G. Fantuzzi,et al.  Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice , 2008, Proceedings of the National Academy of Sciences.

[9]  M. Lynch,et al.  IL‐1F5 mediates anti‐inflammatory activity in the brain through induction of IL‐4 following interaction with SIGIRR/TIR8 , 2008, Journal of neurochemistry.

[10]  A. Pshezhetsky,et al.  Development of a Novel Noncompetitive Antagonist of IL-1 Receptor1 , 2008, The Journal of Immunology.

[11]  Sheetal Sharma,et al.  The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines1 , 2008, The Journal of Immunology.

[12]  Ashley M. Miller,et al.  IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.

[13]  K. Nakanishi,et al.  Protective Effect of IL-18 on Kainate- and IL-1β-Induced Cerebellar Ataxia in Mice1 , 2008, The Journal of Immunology.

[14]  J. O’Shea,et al.  Th17 cells: a new fate for differentiating helper T cells , 2008, Immunologic research.

[15]  B. Hassan,et al.  A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls , 2008, Inflammation.

[16]  M. Huber,et al.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells , 2007, Proceedings of the National Academy of Sciences.

[17]  Y. Sharabi,et al.  Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. , 2007, Atherosclerosis.

[18]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[19]  A. Martini,et al.  Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.

[20]  C. Dinarello Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity. , 2007, Arthritis and rheumatism.

[21]  R. Kastelein,et al.  IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.

[22]  F. Sallusto,et al.  Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.

[23]  G. Dubyak,et al.  Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.

[24]  C. Sasakawa,et al.  Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages , 2007, PLoS pathogens.

[25]  T. Naka,et al.  IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells , 2007, Proceedings of the National Academy of Sciences.

[26]  Junichi Tsukada,et al.  Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. , 2007, Molecular immunology.

[27]  E. Zorrilla,et al.  Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency , 2007, Proceedings of the National Academy of Sciences.

[28]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[29]  M. Gadina,et al.  IL-33: A Sheep in Wolf’s Clothing? , 2007, Science's STKE.

[30]  Richard T. Lee,et al.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.

[31]  S. Park,et al.  P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. , 2007, Haematologica.

[32]  P. Vandenabeele,et al.  Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. , 2007, Immunity.

[33]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[34]  C. Dinarello,et al.  Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α , 2007, Proceedings of the National Academy of Sciences.

[35]  J. Tschopp,et al.  A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.

[36]  N. Rothwell,et al.  Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death , 2007, Journal of Cell Science.

[37]  Yoichiro Iwakura,et al.  Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. , 2007, Cancer research.

[38]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[39]  F. Martinon,et al.  Inflammatory caspases and inflammasomes: master switches of inflammation , 2007, Cell Death and Differentiation.

[40]  J. Meer,et al.  Physiology and Pharmacology of Temperature Regulation Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes , 2006 .

[41]  C. Dinarello,et al.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor , 2006, Proceedings of the National Academy of Sciences.

[42]  A. Surprenant,et al.  Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.

[43]  D. Chang,et al.  Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma , 2006, Gene Therapy.

[44]  N. Kamatani,et al.  Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.

[45]  B. Becher,et al.  Interleukin 18–independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation , 2006, Nature Immunology.

[46]  S. Holland,et al.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. , 2006, The New England journal of medicine.

[47]  K. Mills,et al.  A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.

[48]  T. Yakovleva,et al.  Characterization of Binding Properties of ICAM‐1 Peptides to LFA‐1: Inhibitors of T‐cell Adhesion , 2006, Chemical biology & drug design.

[49]  L. Hazlett,et al.  SIGIRR Promotes Resistance against Pseudomonas aeruginosa Keratitis by Down-Regulating Type-1 Immunity and IL-1R1 and TLR4 Signaling1 , 2006, The Journal of Immunology.

[50]  W. Alexander,et al.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. , 2006, The Journal of clinical investigation.

[51]  Shizuo Akira,et al.  Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance , 2006, Nature Medicine.

[52]  C. Gabay,et al.  The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes , 2006, Arthritis research & therapy.

[53]  S. Nakae,et al.  Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. , 2006, International immunology.

[54]  D. Boraschi,et al.  The interleukin-1 receptor family. , 2006, Vitamins and hormones.

[55]  J. Nerup,et al.  Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans , 2006, Diabetologia.

[56]  L. G. Volkert,et al.  Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis , 2006, Retrovirology.

[57]  G. Dubyak,et al.  Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-κB-Driven Protein Synthesis1 , 2005, The Journal of Immunology.

[58]  C. Dinarello,et al.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.

[59]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[60]  V. Johnson,et al.  Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. , 2005, The Journal of allergy and clinical immunology.

[61]  N. Rothwell,et al.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  Xiaoxia Li,et al.  SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms* , 2005, Journal of Biological Chemistry.

[63]  C. Dinarello The many worlds of reducing interleukin-1. , 2005, Arthritis and rheumatism.

[64]  H. Carlsen,et al.  Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. , 2005, Arthritis and rheumatism.

[65]  C. Dinarello,et al.  Rapid responses to anakinra in patients with refractory adult-onset Still's disease. , 2005, Arthritis and rheumatism.

[66]  V. Pascual,et al.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.

[67]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[68]  R. Sluyter,et al.  P2X7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate-induced interleukin-18 release from human monocytes , 2004, Genes and Immunity.

[69]  C. Dinarello Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. , 2004, Current opinion in pharmacology.

[70]  C. Dinarello,et al.  Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. , 2004, The Biochemical journal.

[71]  K. Beaman,et al.  Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1 beta secretion in human macrophages. , 2004, Human immunology.

[72]  J. Sturis,et al.  Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. , 2004, Diabetes.

[73]  I. McInnes,et al.  A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST21 , 2004, The Journal of Immunology.

[74]  M. Torrisi,et al.  Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[75]  G. Dubyak,et al.  Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. , 2004, American journal of physiology. Cell physiology.

[76]  J. Sims,et al.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.

[77]  J. Wiley,et al.  Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes1 , 2004, The Journal of Immunology.

[78]  C. Garlanda,et al.  Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[80]  C. Dinarello,et al.  The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  D. Yoon,et al.  Identification of a Critical Ig-Like Domain in IL-18 Receptor α and Characterization of a Functional IL-18 Receptor Complex 1 , 2003, The Journal of Immunology.

[82]  G. Stark,et al.  SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.

[83]  M. Haniuda,et al.  Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[84]  S. Nakae,et al.  IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[85]  D. Kastner,et al.  Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. , 2003, Molecular cell.

[86]  Y. Iwakura,et al.  IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Andrea Vondracek,et al.  Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein 1 , 2003, The Journal of Immunology.

[88]  M. Lotze,et al.  Innate Immunity Mediated by the Cytokine IL-1 Homologue 4 (IL-1H4/IL-1F7) Induces IL-12-Dependent Adaptive and Profound Antitumor Immunity1 , 2003, The Journal of Immunology.

[89]  Scott Carver,et al.  Cytokine traps: multi-component, high-affinity blockers of cytokine action , 2003, Nature Medicine.

[90]  K. Wilson,et al.  Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization. , 2002, Biochemistry.

[91]  E. Remmers,et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.

[92]  C. Dinarello,et al.  A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[93]  G. Hitman,et al.  Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. , 2002, Arthritis and rheumatism.

[94]  S. Akira,et al.  IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[95]  S. Argov,et al.  Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice. , 2002, European cytokine network.

[96]  John C. Lee,et al.  Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. , 2002, Cytokine.

[97]  D. Yoon,et al.  Identification of Amino Acid Residues Critical for Biological Activity in Human Interleukin-18* , 2002, The Journal of Biological Chemistry.

[98]  S. Nakae,et al.  Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production , 2001 .

[99]  H. Okamura,et al.  Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells1 , 2001, The Journal of Immunology.

[100]  P. Dawson,et al.  Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[101]  R. Kolodner,et al.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.

[102]  B. Moss,et al.  Correspondence of the Functional Epitopes of Poxvirus and Human Interleukin-18-Binding Proteins , 2001, Journal of Virology.

[103]  R. Kastelein,et al.  Two Novel IL-1 Family Members, IL-1δ and IL-1ε, Function as an Antagonist and Agonist of NF-κB Activation Through the Orphan IL-1 Receptor-Related Protein 21 , 2001, The Journal of Immunology.

[104]  M. Vidal,et al.  EVIDENCE THAT HAX-1 IS AN INTERLEUKIN-1α N-TERMINAL BINDING PROTEIN , 2001 .

[105]  J. Miyazaki,et al.  Cutting Edge: IL-18-Transgenic Mice: In Vivo Evidence of a Broad Role for IL-18 in Modulating Immune Function , 2001, The Journal of Immunology.

[106]  J. E. Ford,et al.  Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member* , 2001, The Journal of Biological Chemistry.

[107]  G. Fantuzzi,et al.  A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. , 2001, Cytokine.

[108]  K. Tracey,et al.  HMG‐1 REDISCOVERED AS A CYTOKINE , 2001, Shock.

[109]  H. Okamura,et al.  Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. , 2001, Cytokine & growth factor reviews.

[110]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[111]  H. Young,et al.  Functional Reconstitution and Regulation of IL-18 Activity by the IL-18Rβ Chain1 , 2001, The Journal of Immunology.

[112]  Phillip E. Risser,et al.  IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. , 2001, Cytokine.

[113]  R. Herbst,et al.  A tissue specific IL‐1 receptor antagonist homolog from the IL‐1 cluster lacks IL‐1, IL‐1ra, IL‐18 and IL‐18 antagonist activities , 2000, European journal of immunology.

[114]  R. Kastelein,et al.  Computational identification, cloning, and characterization of IL-1R9, a novel interleukin-1 receptor-like gene encoded over an unusually large interval of human chromosome Xq22.2-q22.3. , 2000, Genomics.

[115]  C. Gabel,et al.  ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood , 2000, The Journal of Immunology.

[116]  D. Neumann,et al.  The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function1 , 2000, The Journal of Immunology.

[117]  M. Zocchi,et al.  Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells. , 2000, Blood.

[118]  S. Busfield,et al.  Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. , 2000, Genomics.

[119]  M. Kurimoto,et al.  IFN-γ-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12 , 2000, The Journal of Immunology.

[120]  G. Duff,et al.  Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene , 2000, The Journal of experimental medicine.

[121]  S. Nakae,et al.  Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice , 2000, The Journal of experimental medicine.

[122]  I. McInnes,et al.  A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.

[123]  J. E. Ford,et al.  IL1HY1: A novel interleukin-1 receptor antagonist gene. , 1999, Biochemical and biophysical research communications.

[124]  G. Fantuzzi,et al.  IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor , 1999 .

[125]  S. Akira,et al.  Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.

[126]  Lin Jun,et al.  A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation , 1999, Nature Genetics.

[127]  C. Coeshott,et al.  Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Torrisi,et al.  The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.

[129]  M. Netea,et al.  Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha. , 1999, Journal of immunology.

[130]  G. Fantuzzi,et al.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[131]  M. Pras,et al.  MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[132]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[133]  K. McIntyre,et al.  IL-1 receptor accessory protein is an essential component of the IL-1 receptor. , 1998, Journal of immunology.

[134]  T. Born,et al.  Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.

[135]  R. Klemenz,et al.  The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. , 1998, Journal of immunology.

[136]  T. Bártfai,et al.  Interleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor , 1998, FEBS letters.

[137]  Masatoshi Suzuki,et al.  Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.

[138]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[139]  G. Fantuzzi,et al.  IL-1β mediates leptin induction during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  K. Torigoe,et al.  Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.

[141]  G. Fantuzzi,et al.  Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. , 1997, Journal of immunology.

[142]  R. Locksley,et al.  The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein , 1997 .

[143]  S. Paul,et al.  Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[144]  G. Fantuzzi,et al.  Effect of endotoxin in IL-1 beta-deficient mice. , 1996, Journal of immunology.

[145]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[146]  M. Gayle,et al.  T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*) , 1996, The Journal of Biological Chemistry.

[147]  S. Dower,et al.  IL-1Rrp Is a Novel Receptor-like Molecule Similar to the Type I Interleukin-1 Receptor and Its Homologues T1/ST2 and IL-1R AcP (*) , 1996, The Journal of Biological Chemistry.

[148]  J. Sinacore,et al.  Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[149]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[150]  A. Shaw,et al.  Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.

[151]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[152]  C. Dinarello,et al.  Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. , 1995, Kidney international.

[153]  P. Bongrand,et al.  Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. , 1994, Blood.

[154]  A. Mantovani,et al.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.

[155]  L. Gehrke,et al.  Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 beta mRNA show unequal IL-1 beta protein accumulation but similar polyribosome profiles. , 1994, Journal of immunology.

[156]  M. Busslinger,et al.  Alternative promoter usage of the Fos‐responsive gene Fit‐1 generates mRNA isoforms coding for either secreted or membrane‐bound proteins related to the IL‐1 receptor. , 1994, The EMBO journal.

[157]  J. Maier,et al.  Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells , 1994, Molecular and cellular biology.

[158]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[159]  C. Dinarello,et al.  Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[160]  J. Voorhees,et al.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis. , 1992, The Journal of clinical investigation.

[161]  C. Dinarello,et al.  Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. , 1990, The Journal of biological chemistry.

[162]  P. Ghezzi,et al.  IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. , 1990, Journal of immunology.

[163]  P. Libby,et al.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. , 1987, Journal of immunology.

[164]  D. Boraschi,et al.  A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. , 1986, Journal of immunology.

[165]  J. Nerup,et al.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. , 1986, Science.

[166]  E. Unanue,et al.  Identification of a membrane-associated interleukin 1 in macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.